Thematic Take

Powered by

Cyrus Mewawalla, Head of Thematic Intelligence, GlobalData

Foreword: Cyber risk is higher than ever

At GlobalData, we define a theme as any issue that keeps a business leader awake at night. Companies are impacted by multiple themes that frequently conflict with one another. What is needed is an effective methodology that reflects, understands, and reconciles these conflicts.  

Our thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. Viewing the world’s data by themes makes it easier to make critical decisions. Companies that invest in the right themes become success stories. Those that miss the essential themes in their industry end up as failures. 

The cybersecurity landscape is complex. Today’s always-connected world offers many opportunities for cyberattackers to disrupt countries, organisations, and individuals. 

A challenging worldwide geopolitical environment, exacerbated by the Covid-19 pandemic and the Russia-Ukraine conflict, has given cyberattackers an uneven playing field, which they actively exploit.  

Those not after money are often motivated by revenge, and these types of attacks typically involve a disgruntled employee or disaffected customer. Other threat actors include hacktivists trying to gain attention for their cause, terrorists intent on damaging critical national infrastructure, or nation-states using cyber warfare against other countries. 

Cyber risk is higher than ever, and the consequences of attacks are significant. According to Cybersecurity Ventures, global cybercrime will reach $10.5tr annually by 2025. Tackling this issue requires investment, and GlobalData forecasts that cybersecurity revenues will reach $344bn worldwide by 2030.

Go to article: Home | Pathbreakers: The journey of first genericsGo to article: Editor's letterGo to article: ContentsGo to article: wek-tec Company InsightGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Datwyler Company InsightGo to article: DatwylerGo to article: VeevaGo to article: In DepthGo to article: Pathbreakers: The journey of first genericsGo to article: Managed access programmes: Reaching patients in needGo to article: Insulin pricing in flux as major pharma players take actionGo to article: As RSV vaccine approvals loom, regulators need to devise vaccination strategiesGo to article: Build API facilities in Central and Eastern Europe to fix drug shortages, says report Go to article: CfPIEGo to article: BEA TechnologiesGo to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: ForewordGo to article: The state of cybersecurity in 2023Go to article: The history of cybersecurityGo to article: The impact of cybersecurity on the pharmaceutical industryGo to article: Case studies: cybersecurity in the pharmaceutical industryGo to article: Latest news: cybersecurity in pharma Go to article: Q&A with GlobalData thematic analystGo to article: Key cybersecurity trends in PharmaGo to article: Cybersecurity in pharma: Securing the future Go to article: Deal activity related to cybersecurity in the pharmaceutical industry since 2018Go to article: Cybersecurity hiring trends in the global pharmaceutical industry since 2020Go to article: Cybersecurity patent applications in the global pharma industry since 2020Go to article: Mentions of cybersecurity in pharma industry company filings since 2020 Go to article: GlobalData Thematic IntelligenceGo to article: Sponsored SupplementsGo to article: ListingsGo to article: EventsGo to article: AwardsGo to article: Buyer's GuidesGo to article: Next issue